Smilaf Tablets 100mg

Smilaf Tablets 100mg, containing Peficitinib hydrobromide, is manufactured by Astellas Pharma (YJ code: 3999046F2020, standard: 100mg 1 tablet). Peficitinib is a Janus kinase (JAK) inhibitor used for treating moderate to severe rheumatoid arthritis in adults, especially when other therapies have not been effective. It functions by inhibiting JAK enzymes to help reduce inflammation.